Following people treated for neurocysticercosis, a brain infection from pork tapeworm larvae
Studies what affects long-term health in people treated for neurocysticercosis.
Key facts
- Who runs it
- National Institute of Allergy and Infectious Diseases (NIAID)
- Where
- Bethesda, United StatesSee the site
- Trial code
- Registry title
- Natural History of Treated Neurocysticercosis and Long-Term Outcomes
- Status
- Recruiting
- People taking part
- 500 people, planned
- Started
- 7 Oct 1985
- Type of study
- Observational, 6 groups
- Record updated
- 29 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people with proven or likely neurocysticercosis, a brain infection caused by the larvae of the pork tapeworm. It also takes adults who may have been exposed to this tapeworm where it is common.
- Age
- Arms 1-5: 3 years and older. Arm 6 (exposure group): 18 years and older. The record gives an upper limit of 99 Years.
- Sex
- All sexes can join.
- Disease stage
- Any type of neurocysticercosis: in the space around the brain (subarachnoid), in the brain's fluid pockets (ventricular), cysts in the brain tissue that have not hardened into calcium, or hardened (calcified) cysts with or without seizures. Arm 6 is for people whose history shows they may have been exposed.
The registry criteria, word for word
Show all 7 criteriaShow less
Who cannot take part
- Not applicable
Other criteria
- INCLUSION CRITERIA:; Arms 1-5 (NCC):
- Aged 3 years and older
- Ability of participant (or legally authorized representative, LAR) to understand and the willingness to sign a written informed consent document
- Patients with proven or likely NCC; Arm 6 (Endemic Exposures):
- Patient with epidemiologic history compatible with possible exposure to NCC
- Aged 18 years and older
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 3 and 99 years old?
Where in United States
- National Institutes of Health Clinical CenterBethesda, United StatesContact: Perla M Adames Castillo, R.N.Taking people
About the trial
What the trial wants to find out
Neurocysticercosis is a brain disease due to the larval stage of the pork tapeworm (Taenia solium). The most common symptoms patient experience from infection inside the substance of the brain (parenchymal disease) are seizures and headaches. When the infection is either inside the fluid pockets inside the brain (ventricular disease) or in the space around the brain (subarachnoid disease) patients can have chronic headaches, relapsing aseptic meningitis, hydrocephalus, stroke, and may require neurosurgical intervention. The purpose of this study is to treat patients with anthelmintic therapy (praziquantel and/or albendazole) and anti-inflammatories in alignment with currently accepted best practices and guidelines, depending on the neurocysticercosis subtype. The purpose of the study is to better understand and characterize clinical, biologic, and management factors during treatment that influence long term outcomes. In order to understand this further we collect patient clinical information, patient survey responses, blood, urine samples, and additional cerebral spinal fluid if already being collected for clinical care.
The 6 groups in the trial
- Arm 1
Subarachnoid (racemose) neurocysticercosis
- Arm 2
Ventricular without other viable disease
- Arm 3
Parenchymal cyst(s)--non-calcified parenchymal disease at time of referral
- Arm 4
Calcified parenchymal disease with symptoms (seizures)
- Arm 5
Calcified parenchymal disease without symptoms
- Arm 6
Endemic exposure--subjects with compatible epidemiologic exposure to T. solium
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Natural History of Treated Neurocysticercosis and Long-Term Outcomes
- Plain-language title
- Following people treated for neurocysticercosis, a brain infection from pork tapeworm larvaeGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT00001205, who can take part
- Record updated
- 29 October 2026